ro 32-3555 has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grandgirard, D; Leib, SL; Leppert, D; Liechti, FD | 1 |
Geary, MB; Hammert, WC; Loiselle, AE; O'Keefe, RJ; Orner, CA | 1 |
Bottomley, KM; Brewster, M; Greenham, AK; Lewis, EJ; Wilson, KL | 1 |
3 other study(ies) available for ro 32-3555 and Disease Models, Animal
Article | Year |
---|---|
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Apoptosis; Brain Injuries; Collagen; Cytokines; Disease Models, Animal; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Meningitis, Pneumococcal; Peroxidase; Rats; Sulfonamides; Weight Loss | 2014 |
Low-Dose and Short-Duration Matrix Metalloproteinase 9 Inhibition Does Not Affect Adhesion Formation during Murine Flexor Tendon Healing.
Topics: Analysis of Variance; Animals; Biomechanical Phenomena; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Random Allocation; Reference Values; Tendon Injuries; Tensile Strength; Tissue Adhesions; Wound Healing | 2016 |
Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis.
Topics: Animals; Cartilage, Articular; Disease Models, Animal; Imidazoles; Knee Joint; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Microradiography; Osteoarthritis; Protease Inhibitors | 1998 |